Salt Lake City, UT, United States of America

Jerry Lanchbury

This inventor holds 13 USPTO granted patents and 22 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Cancer Diagnostics. Top assignees: Myriad Genetics, Inc., The University of Texas System, Laboratory Corporation of America Holdings. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jerry Lanchbury. Retrieved from https://idiyas.com/inventor/jerry-lanchbury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 22)

% Patents Active = 84.6

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 9 (Patent Applications = 17)

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 34(Granted Patents)

Company Filing History:

12 out of 123

Myriad Genetics, Inc.

patents

2 out of 5,645

The University of Texas System

patents

1 out of 128

Laboratory Corporation of America Holdings

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Loss Of Heterozygosity

Allelic Imbalance

Biomarker Assessment

Cancer Treatment

Inflammatory Disease

Gene Copy Number Profiling

Disease Activity Score

Depression-Related Gene

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12674207 - Methods and materials for assessing loss of heterozygosity (2026-07-07),

2. 12595513 - Methods and materials for assessing loss of heterozygosity (2026-04-07),

3. 12392785 - Adjusted multi-biomarker disease activity score for inflammatory disease assessment (2025-08-19),

4. 11225685 - Methods and materials for assessing allelic imbalance (2022-01-18),

5. 11174519 - Method of treating cancer (2021-11-16),

6. 10851425 - Method for treating cancer (2020-12-01),

7. 10626449 - Methods and materials for assessing allelic imbalance (2020-04-21),

8. 10612098 - Methods and materials for assessing loss of heterozygosity (2020-04-07),

9. 9574229 - Methods and materials for assessing allelic imbalance (2017-02-21),

10. 9388472 - Methods and materials for assessing loss of heterozygosity (2016-07-12),

11. 9279156 - Methods and materials for assessing allelic imbalance (2016-03-08),

12. 7794933 - Depression-related gene (2010-09-14),

13. 7662566 - Gene copy number profiling (2010-02-16),

Title: The Innovative Journey of Jerry Lanchbury

Introduction: Jerry Lanchbury, a visionary inventor based in Salt Lake City, UT, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Jerry Lanchbury's most recent patents include a cutting-edge artificial intelligence algorithm for predictive analytics and a revolutionary wearable device for monitoring vital signs in real-time.

Career Highlights: With a career spanning over two decades, Jerry Lanchbury has established himself as a leading figure in the tech industry. He has held key positions in various tech companies, leading research and development teams to create innovative solutions.

Collaborations: Throughout his career, Jerry Lanchbury has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions worldwide. His collaborative efforts have resulted in pioneering inventions that have shaped the future of technology.

Conclusion: Jerry Lanchbury's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of technology. His remarkable inventions continue to inspire and drive progress in the industry.

Profile summary based on public USPTO records.